Literature DB >> 18376165

The correlation between ketamine and posttraumatic stress disorder in burned service members.

Laura L McGhee1, Christopher V Maani, Thomas H Garza, Kathryn M Gaylord, Ian H Black.   

Abstract

BACKGROUND: Predisposing factors for posttraumatic stress disorder (PTSD) include experiencing a traumatic event, threat of injury or death, and untreated pain. Ketamine, an anesthetic, is used at low doses as part of a multimodal anesthetic regimen. However, since ketamine is associated with psychosomatic effects, there is a concern that ketamine may increase the risk of developing PTSD. This study investigated the prevalence of PTSD in Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) service members who were treated for burns in a military treatment center.
METHODS: The PTSD Checklist-Military (PCL-M) is a 17-question screening tool for PTSD used by the military. A score of 44 or higher is a positive screen for PTSD. The charts of all OIF/OEF soldiers with burns who completed the PCL-M screening tool (2002-2007) were reviewed to determine the number of surgeries received, the anesthetic regime used, including amounts given, the total body surface area burned, and injury severity score. Morphine equivalent units were calculated using standard dosage conversion factors.
RESULTS: The prevalence of PTSD in patients receiving ketamine during their operation(s) was compared with patients not receiving ketamine. Of the 25,000 soldiers injured in OIF/OEF, United States Army Institute of Surgical Research received 603 burned casualties, of which 241 completed the PCL-M. Of those, 147 soldiers underwent at least one operation. Among 119 patients who received ketamine during surgery and 28 who did not; the prevalence of PTSD was 27% (32 of 119) versus 46% (13 of 28), respectively (p = 0.044).
CONCLUSIONS: Contrary to expectations, patients receiving perioperative ketamine had a lower prevalence of PTSD than soldiers receiving no ketamine during their surgeries despite having larger burns, higher injury severity score, undergoing more operations, and spending more time in the ICU.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18376165     DOI: 10.1097/TA.0b013e318160ba1d

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  43 in total

1.  Remembered for forgetting.

Authors:  Cassandra Willyard
Journal:  Nat Med       Date:  2012-04-05       Impact factor: 53.440

Review 2.  Prevention of Trauma and Stressor-Related Disorders: A Review.

Authors:  Jonathon R Howlett; Murray B Stein
Journal:  Neuropsychopharmacology       Date:  2015-08-28       Impact factor: 7.853

3.  Memories reactivated under ketamine are subsequently stronger: A potential pre-clinical behavioral model of psychosis.

Authors:  Michael J Honsberger; Jane R Taylor; Philip R Corlett
Journal:  Schizophr Res       Date:  2015-02-24       Impact factor: 4.939

4.  Ketamine accelerates fear extinction via mTORC1 signaling.

Authors:  Matthew J Girgenti; Sriparna Ghosal; Dora LoPresto; Jane R Taylor; Ronald S Duman
Journal:  Neurobiol Dis       Date:  2016-12-30       Impact factor: 5.996

Review 5.  Pharmacological treatment of PTSD - established and new approaches.

Authors:  Thomas Steckler; Victoria Risbrough
Journal:  Neuropharmacology       Date:  2011-06-29       Impact factor: 5.250

Review 6.  Surgically induced neuropathic pain: understanding the perioperative process.

Authors:  David Borsook; Barry D Kussman; Edward George; Lino R Becerra; Dennis W Burke
Journal:  Ann Surg       Date:  2013-03       Impact factor: 12.969

Review 7.  Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine.

Authors:  Liana Fattore; Alessandro Piva; Mary Tresa Zanda; Guido Fumagalli; Cristiano Chiamulera
Journal:  Psychopharmacology (Berl)       Date:  2017-11-25       Impact factor: 4.530

8.  Ketamine Alleviates Fear Generalization Through GluN2B-BDNF Signaling in Mice.

Authors:  Muhammad Asim; Bo Hao; Yu-Han Yang; Bu-Fang Fan; Li Xue; Yan-Wei Shi; Xiao-Guang Wang; Hu Zhao
Journal:  Neurosci Bull       Date:  2019-08-23       Impact factor: 5.203

9.  Posttraumatic Stress Disorder: an integrated overview and neurobiological rationale for pharmacology.

Authors:  Benjamin Kelmendi; Thomas G Adams; Steven Southwick; Chadi G Abdallah; John H Krystal
Journal:  Clin Psychol (New York)       Date:  2017-07-18

10.  Anxiolytic effects of ketamine in animal models of posttraumatic stress disorder.

Authors:  Li-Ming Zhang; Wen-Wen Zhou; Ya-Jun Ji; Ying Li; Nan Zhao; Hong-Xia Chen; Rui Xue; Xin-Guo Mei; You-Zhi Zhang; Heng-Lin Wang; Yun-Feng Li
Journal:  Psychopharmacology (Berl)       Date:  2014-09-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.